Dermatology Medical News about Lupus Erythematosus, Systemic

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cutaneous Lupus Erythematosus: Issues in Diagnosis and Treatment
American Journal of Clinical Dermatology, 10/20/09

Walling HW et al. – Treatments for cutaneous LE initially include preventive (e.g. photoprotective) strategies and topical therapies (corticosteroids and topical calcineurin inhibitors). For skin disease not controlled with these interventions, oral antimalarial agents (most commonly hydroxychloroquine) are often beneficial. Additional systemic therapies may be subdivided into conventional treatments (including corticosteroids, methotrexate, thalidomide, retinoids, dapsone, and azathioprine) and newer immunomodulatory therapies (including efalizumab, anti–tumor necrosis factor agents, intravenous immunoglobulin, and rituximab).

<< Previous
Topical Clobetasol Propionate in the Treatment of Psoriasis: A...

Next >>
Rates of Skin Cancer Screening and Prevention Counseling by US...

Ten cases of systemic lupus erythematosus related to hepatitis B vaccine
Lupus, 11/09/09 Relevance Score: 84%

Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09 Relevance Score: 84%

Infection—genetics relationship in systemic lupus erythematosus
Lupus, 11/05/09 Relevance Score: 83%

Molecular mimicry in systemic lupus erythematosus
Lupus, 11/13/09 Relevance Score: 82%

Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09 Relevance Score: 82%